These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3012924)

  • 1. The GABAergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate.
    Coiro V; Davoli C; Volpi R; Sorini E; Voltini E; Rossi G; Delsignore R; Gnudi A; Chiodera P
    Acta Diabetol Lat; 1986; 23(1):51-5. PubMed ID: 3012924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men.
    Coiro V; Capretti L; Bianconi L; Castelli A; Cerri L; Roberti G; Marcato A; Volpi R; Chiodera P
    Horm Metab Res; 1991 Dec; 23(12):600-4. PubMed ID: 1663914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.
    Coiro V; Volpi R; Maffei ML; Caiazza A; Caffarri G; Capretti L; Colla R; Chiodera P
    Eur J Endocrinol; 1994 Jul; 131(1):50-5. PubMed ID: 8038904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly.
    Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G
    Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Beneventi F; Trimarchi G; Fioretti P
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):245-52. PubMed ID: 6426828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
    Sarnacchiaro F; Colao A; Merola B; Di Sarno A; Landi ML; Di Somma C; Ferone D; Tolino A; Lombardi G
    J Endocrinol Invest; 1997 Oct; 20(9):513-8. PubMed ID: 9413804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia.
    Monteleone P; Zontini G; Steardo L
    Psychoneuroendocrinology; 1985; 10(4):475-80. PubMed ID: 3003777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.
    Melis GB; Paoletti AM; Mais V; Mastrapasqua NM; Strigini F; Fruzzetti F; Guarnieri G; Gambacciani M; Fioretti P
    J Clin Endocrinol Metab; 1982 Mar; 54(3):485-9. PubMed ID: 6799535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the GABAergic agent sodium valproate on the arginine vasopressin responses to hypertonic stimulation and upright posture in man.
    Chiodera P; Gnudi A; Volpi R; Marchesi C; Marchesi M; Davoli D; Capretti L; Coiro V
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):389-95. PubMed ID: 2557180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired insulin secretion in human diabetes mellitus. Effect of pharmacological activation of gamma-aminobutyric acid system.
    Quatraro A; Consoli G; Stante A; Minei A; Ceriello A; Passariello N; Giugliano D
    Acta Diabetol Lat; 1986; 23(1):23-8. PubMed ID: 3012923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Kemeny A; Strigini F; Boldrini A; Fioretti P
    J Clin Endocrinol Metab; 1984 Jan; 58(1):201-5. PubMed ID: 6417154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term treatment with sodium valproate on gonadotrophin and prolactin secretion in paediatric patients.
    Masala A; Meloni T; Alagna S; Rovasio PP; Rassu S; Mele G; Franca V
    Br J Clin Pharmacol; 1981 Dec; 12(6):845-8. PubMed ID: 6803821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin response to dopamine and valproate administration in breast cancer patients.
    Stalldecker GB; Pigni J; Fuentes AM; Vegh I
    Biomed Pharmacother; 1989; 43(4):301-6. PubMed ID: 2506942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of the GABAergic agent sodium valproate on the oxytocin responses to angiotensin II and insulin-induced hypoglycemia in normal men.
    Chiodera P; Coiro V
    Horm Res; 1991; 36(1-2):27-31. PubMed ID: 1814797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sodium valproate on medium-late luteal phase pulsatile LH secretion in normal women.
    Lado Abeal J; Rey Losada C; Cabezas Agricola JM; Cabezas-Cerrato J
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):127-31. PubMed ID: 8306471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
    Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P
    Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the effect of gamma-aminobutyric acid on prolactin secretion during sexual maturation in female rats.
    Moguilevsky JA; Carbone S; Szwarcfarb B
    Endocrinology; 1992 Jul; 131(1):458-62. PubMed ID: 1319326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation.
    Lee WS; Limmroth V; Ayata C; Cutrer FM; Waeber C; Yu X; Moskowitz MA
    Br J Pharmacol; 1995 Sep; 116(1):1661-7. PubMed ID: 8564234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of preoptic GABA release caused by push-pull-perfusion with sodium valproate.
    Wolf R; Tscherne U; Emrich HM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):658-63. PubMed ID: 3149723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotrophin, cortisol, prolactin and growth hormone responses to insulin-induced hypoglycaemia in normal subjects given sodium valproate.
    Abraham RR; Dornhorst A; Wynn V; Altaher AR; Campbell EA; Beckford U; Watts SM; Nicholson SA; Gillham B; Thody A
    Clin Endocrinol (Oxf); 1985 May; 22(5):639-44. PubMed ID: 2992848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.